Five young scientists were honored in Innsbruck on Wednesday for their internationally outstanding work: The Life Sciences Research Awards Austria 2025 of the Austrian Society for Molecular Biosciences and Biotechnology...
Some of today’s most pressing health challenges include emerging pathogens, rising antibiotic resistance, and chronic infections. To address these issues, a new Helmholtz research building is being constructed in...
A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new way to fine-tune genetic material. Their study, published in Nature Biotechnology, describes an...
Antimicrobial resistance is still an underestimated problem. Resistant bacteria are by no means only found in hospitals, they also occur in the natural environment. Prof. Katharina Schaufler and her team from the...
Itaconate is a small molecule produced in our bodies to fight bacteria and modulate immune responses. However, how itaconate travels through the body is not well understood. To close this gap, an international team of...
On 11 September 2025, the Helmholtz Institute for One Health (HIOH) in Greifswald laid the foundation stone for its new research building. The festive ceremony brought together numerous guests from science, politics and...
Bacteriophages, or phages for short, are viruses that infect bacteria. Using phages therapeutically could be very useful in fighting antibiotic-resistant pathogens, but the molecular interactions between phages and host...
Mpox continues to pose a growing health threat in various African countries, such as the Democratic Republic of the Congo, where frequent zoonotic spillovers occur across the country and occasionally lead to major...
In the fight against multi-resistant bacteria, bacteriophages—the natural enemies of bacteria—are attracting increasing research interest. However, the targeted therapeutic application of these “bacterial killers”...
